Less Ads, More Data, More Tools Register for FREE

Pin to quick picksOrigin Regulatory News (OGN)

Share Price Information for Origin (OGN)

Share Price is delayed by 15 minutes
Get Live Data
365.00    0.00 (0.00%)
Bid:
360.00
Ask:
370.00
Spread: 10.00 (2.778%)
Market Cap: £392.33m
OGN Live PriceLast checked at - London Stock Exchange

Intraday Origin Share Chart

Directorate Update

1 Oct 2018 16:59

RNS Number : 5966C
Origin Enterprises Plc
01 October 2018
 

 

Directorate Update

1 October 2018

 

Origin Enterprises plc ('Origin' or the 'Company') announces the appointment of Sean Coyle (45) to the Board of the Company with effect from today 1 October 2018, as previously outlined in the regulatory announcements of 7 June 2018 and 26 September 2018. Sean was appointed Chief Financial Officer on 1 September 2018.

 

Full details of his current and past directorships within the last five years are outlined below. None of these entities have any relationship with Origin Enterprises plc.

 

There are no other items requiring disclosure in accordance with Schedule 2(g) of the AIM Rules for Companies or the ESM Rules for Companies. Sean Coyle currently has an interest in 7,000 ordinary shares in Origin.

 

Current Directorships

 

None

 

Past Directorships

Sean Gerard Coyle was a director or partner of the following within the last five years:

 

Steel Eagle Holdings, Inc

Dull Investment Corporation

Sharp Clinical Services Incorporated

Sharp Corporation

Ashfield Healthcare Communications, LLC

Ballina Pharma Inc

Magna Healthcare Inc

Ashfield Healthcare LLC

UDG Healthcare Limited

UDG Healthcare UK (Holdco) Limited

Mantis Surgical Limited

Mediscope Limited

Barclay (Northern Ireland) Limited

Klondyke Enterprises Limited

Mansett Limited

Network Hospital Services Limited

Robert Smith & Co. (Derry) Limited

Vector Scientific Limited

Intraveno (N.I.) Limited

New Splint Limited

Unitech Equipment Limited

TD Packaging Limited

Ashfield Alliance Limited

Ashfield Healthcare (Ireland) Limited

Dublin Drug (Investments) Limited

Dublin Drug Company Limited

Dublin Drug Public Limited Company

Dugdale Trading Limited

Marker (U.D.) Ireland Limited

Oremelt Company Unlimited Company

Pharmexx Ireland (Sales Solutions) Limited

UDG Healthcare Ayrtons (Dublin) Limited

UDG Healthcare Finance Limited

UDG Healthcare Ireland Limited

UDG Healthcare Nordic Limited

UDG Healthcare Packaging Group Limited

UDG Healthcare Property Holdings Limited

United Care Limited

Aquilant Analytical Sciences Limited

Aquilant Endoscopy Limited

Aquilant Limited

Aquilant Medical (ROI) Limited

Aquilant Nederland B.V.

Aquilant Northern Ireland Limited

Aquilant Pharmaceuticals Limited

Aquilant Scientific (ROI) Limited

UDG Healthcare Specialist Product Services Limited

Alchem Plc

Pemberton Marketing Limited

Magir Limited

UDG Healthcare Distributors Limited

The Health Insurance Authority

Marker International BV

Magna Finance BV

UniDrug Distribution Group Limited

 

ENDS

 

 

 

 

 

 

Enquiries:

 

Peter Dunne +353 (0)1 563 4965

Company Secretary

Origin Enterprises plc

 

Davy (Nominated Adviser)

Anthony Farrell + 353 (0)1 614 9993

 

 

About Origin Enterprises plc

Origin Enterprises plc is a focused Agri-Services group providing specialist On-Farm Agronomy Services, Digital Agricultural Services and the supply of crop technologies and inputs. The Group has leading market positions in Ireland, the United Kingdom, Belgium, Brazil, Poland, Romania and Ukraine. Origin is listed on the ESM and AIM markets of the Irish and London Stock Exchanges.

 

ESM ticker symbol: OIZ

AIM ticker symbol: OGN

 

Website: www.originenterprises.com

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
STRBUBDGSUGBGIB
Date   Source Headline
31st Mar 20152:15 pmRNSHolding in Company
31st Mar 20157:00 amRNSHolding in Company
27th Mar 20154:15 pmRNSHolding(s) in Company
25th Mar 20154:15 pmRNSARYZTA PLACING
25th Mar 20157:00 amRNSARYZTA announcement
12th Mar 20157:00 amRNSInterim Results Announcement
6th Feb 20154:15 pmRNSHolding(s) in Company
24th Nov 20144:30 pmRNSAGM Results Announcement
24th Nov 20147:00 amRNSTrading Update
15th Oct 20144:30 pmRNSDirector/PDMR Shareholding
29th Sep 20144:30 pmRNSAnnual Report and Accounts 2014
26th Sep 20144:30 pmRNSNotification of Directors' Dealings
24th Sep 20147:00 amRNSPreliminary Results Statement 2014
1st Aug 20148:00 amRNSDirectorate Change
29th May 20144:30 pmRNSDirector's Shareholding
28th May 20147:00 amRNSTrading Update
12th Mar 20144:30 pmRNSDirector's Shareholding
7th Mar 20144:36 pmRNSDirectors' Shareholding
6th Mar 20147:00 amRNSInterim Results Announcement
30th Jan 20147:00 amRNSCompletion of Acquisition
4th Dec 20137:00 amRNSOrganisational Announcement
22nd Nov 20137:01 amRNSDirectors' Shareholding
22nd Nov 20137:00 amRNSResult of Tender Offer
18th Nov 20134:30 pmRNSAnnual and Extraordinary General Meetings
18th Nov 20137:00 amRNSTrading Update
30th Oct 20137:00 amRNSAcquisition in Ukraine
17th Oct 20134:37 pmRNSLaunch of Euro 100 million tender offer
4th Oct 20134:15 pmRNSAnnual Report and Accounts 2013
25th Sep 20137:00 amRNSPreliminary Results Statement 2013
12th Aug 20133:30 pmRNSMarine Proteins and Oils JV interest
4th Jul 20137:00 amRNSDisposal of Marine Proteins and Oils JV interest
28th May 20137:00 amRNSTrading Update
11th Mar 20134:30 pmRNSDirectors' Dealing
6th Mar 20137:00 amRNSIssue of Ordinary Shares
6th Mar 20137:00 amRNSInterim Results Announcement
14th Dec 20125:30 pmRNSDirector's Dealings
26th Nov 20124:30 pmRNS2012 AGM Results
26th Nov 20127:00 amRNSTrading Update
11th Oct 20124:30 pmRNSAnnual Report and Accounts 2012
19th Sep 20127:00 amRNSPreliminary Results Statement
26th Jun 20124:30 pmRNSAnalyst and Investor Meeting
18th Jun 20124:30 pmRNSHolding(s) in Company
28th May 20127:00 amRNSTrading Update
18th May 20124:30 pmRNSNon-Executive Directorate Changes
18th Apr 20124:30 pmRNSNotification of change in Shareholding Interest
18th Apr 20124:30 pmRNSNotification of change in Shareholding
17th Apr 20124:30 pmRNSDirectors' Dealing
13th Apr 20124:30 pmRNSIssue of Ordinary Shares
8th Mar 20127:00 amRNS2012 Interim Results
16th Jan 20127:00 amRNSRebranding of UK agronomy services business

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.